Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 123795
Published online Jan 14, 2027. doi: 10.3748/wjg.123795
Published online Jan 14, 2027. doi: 10.3748/wjg.123795
Figure 8 Proposed mechanism underlying the protective effects of melatonin against pathological angiogenesis in cirrhotic portal hypertension.
Melatonin disrupts the interaction between POMK and VEGFR-2, resulting in reduced VEGFR-2 phosphorylation and attenuation of downstream PLC-γ/ERK1/2 signaling activation. This inhibition suppresses VEGF-induced endothelial cell proliferation and angiogenesis, thereby contributing to the improvement of splanchnic hyperdynamic circulation in cirrhotic portal hypertension. HUVEC: Human umbilical vein endothelial cell.
- Citation: Wu GB, Luo GQ, Chen M, Cai KW, You XT, Han F, Zhang NZ, Luo M, Li Q, Huo HZ, Fan Q. Melatonin attenuates splanchnic hyperdynamic circulation in cirrhotic portal hypertension by disrupting POMK-VEGFR2 interaction. World J Gastroenterol 2027; 33(2): 123795
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/123795.htm
- DOI: https://dx.doi.org/10.3748/wjg.123795